From Afterthought to Design Driver Over the past decade, biomarkers have moved from the margins of oncology clinical trials into their structural core. Where ...

Oncology remains one of the highest-attrition areas in drug development, with only a small minority of candidates entering clinical testing going on to reach app...

The rapid evolution of gene therapies and gene editing modalities in particular is challenging how personalised medicines are developed and evaluated. Many rare ...

Every generation of mammalian cell culture has solved one biological challenge while revealing the next. The earliest researchers sought to keep living cells ali...